Clinical Trials Arena on MSN
Mabwell doses first patient in phase II anti-IL-11 antibody trial
The first patient received dosing at Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback